Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients
Exact Sciences Corp. (NASDAQ: EXAS) announced today it has acquired PreventionGenetics, a genetic testing laboratory, to […]
Univercells Acquires SynHelix, Entering into Synthetic Biology and the Race to Next-generation DNA Synthesis
Univercells S.A. (Univercells) today announces its acquisition of SynHelix, a biotechnology company that aims to debottleneck […]
Babylon Acquires Higi to Extend its Digital-First Healthcare Platform to Millions of People in the U.S.
Babylon today announced the closing on December 31, 2021 of its acquisition of Higi SH […]
Novartis to Acquire Gyroscope Therapeutics, Adding a One-time Gene Therapy That Could Transform Care for Geographic Atrophy, a Leading Cause of Blindness
Novartis announced today that it entered into a definitive agreement to acquire all of the […]
Insightful Science Acquires Protein Metrics to Expand its R&D Solution to Include Proteomics
Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it […]
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the company has entered into a definitive agreement […]
Caixa Capital Risc Leads Sale of Sanifit Therapeutics to Vifor Pharma with Upfront Payment of €205M
Caixa Capital Risc, the venture capital subsidiary of CriteriaCaixa, today announces the sale of its […]
Novo Nordisk to Acquire Dicerna Pharmaceuticals Including the RNAi Research Technology Platform
Novo Nordisk today announced that it has entered into a definitive agreement to acquire Dicerna […]
Generate Life Sciences to be Acquired by CooperCompanies
Generate Life Sciences® announces it has entered into an agreement to be acquired by the publicly […]
CrestOptics Acquired by Apposite Capital LLP to Enable Rapid Commercial Growth and Innovation in Bioimaging
CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more